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ABSTRACT
Nanoparticles have been demonstrated as a promising new generation of specific imaging
agents and targeted delivery vehicles for the diagnosis and treatment of solid tumors.
Nonetheless, for optimal therapy of tumors, the nanoparticles must penetrate the tumor
interstitial matrix to reach the cancer cells. This thesis describes the development of a
multiphoton fluorescence correlation spectroscopy (MPFCS) system and its utilization to
probe the effect of charge on the diffusion of quantum dot (QD) nanocrystals in collagen
and collagen-hyaluronan (HA) composite gel models of human colon adenocarcinoma
(LS174T). The MPFCS system was integrated with a multiphoton laser-scanning
microscope (MPLSM) to enable visualization of QD distribution and collagen
organization, as well as diffusion measurements. QDs of three different charges by
modifying the surface of pre-made CdSe/CdZnS QDs with dihydrolipoic acid (DHLA),
DHLA-polyethyleneglycol (DHLA-PEG) and amino-functionalized DHLA-PEG
(DHLA-PEG-NH 2). Aggregation was observed in QD-DHLA (4-potential = -31.12 mV)
and QD-DHLA-PEG-NH 2 (4-potential =+37.39 mV) samples in gels, but the distribution
of QD-DHLA-PEG (4-potential = -18.16 mV) was uniform. FCS measurements were
performed for each QD sample in both gel models. Experimental data indicated
anomalous subdiffusion of QDs in both gels with all samples having the same time
exponent. The transport coefficient of QD-DHLA-PEG was significantly higher than
QD-DHLA and QD-DHLA-PEG-NH 2. A two-component free diffusion model also
provided a good fit for the data, but did not provide a clear picture on the role of charge
in diffusion. Our experiments suggest that anionic and cationic nanoparticles experience
more hindrance compared to neutral, PEGylated nanoparticles in both collagen and
collagen-HA gels.
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Chapter 1: Introduction
1.1 Background and Motivation
Cancer is the leading cause of death among Americans today. Currently, one in
four deaths in the United States is due to cancer1 . Despite outstanding progress
in fundamental cancer biology over the past quarter century, these advances
have not translated into commensurate advances in the clinic. The main reason
for this disparity is the lack of effective administration of therapeutic agents so
that they will selectively reach the desired targets with minimum or no collateral
damage2. Conventional cancer treatments and diagnostics involve
chemotherapy, surgery, radiation, biopsy and the application of catheters.
Success of cancer therapy is limited due to the lack of early disease detection,
nonspecific systemic distribution, inadequate drug concentrations reaching the
tumor and the inability to monitor therapeutic responses1 .
Nanotechnology is an emerging field that will potentially result in significant
advances in early detection, molecular imaging, assessment of therapeutic
efficacy, targeted and multifunctional therapeutics as well as the prevention and
control of cancer 2. The unique size of nanoparticles (1 - 100nm) offers more
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surface area and functional groups that can be linked to multiple optical,
radioisotopic, or magnetic diagnostic and therapeutic moieties 3. For example,
Abraxane represents a new class of nanoparticles making their way into the
clinic and has successfully been used in women with breast cancer initially
refractory to texane therapy4. Thus, applying to nanotechnology to medicine, in
particular to the war against caner, may introduce a new paradigm in healthcare.
While the future of cancer nanotechnology promises looks bright, nanosized
hybrid therapeutics and drug delivery systems will not be advantageous unless
they (or the drug they release) reach the desired target in effective
concentrations 5,6. Furthermore, poor drug delivery and residence at the target
site can result in significant complications, such as multi-drug resistance 7. In
order to use these nanoparticles effectively, there is a need to establish design
guidelines for their physicochemical properties that will ensure optimal delivery
to tumors.
1.2 Objectives
This thesis describes the development of a multiphoton fluorescence correlation
spectroscopy (MPFCS) system and its utilization to probe the effect of charge on
the diffusion of nanoparticles in the tumor interstitium. The first objective is to
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build a MPFCS system to enable tranport measurements as well as develop
software for the analysis of experimental data. Second, we will characterize and
calibrate our MPFCS system using fluorescent dyes and microspheres of known
diffusion coefficients. Lastly, we will adapt MPFCS to measure the diffusion of
charged QDs in solution as well as in gels developed to resemble the tumor
interstium. When completed, this information will provide guidelines on the
design of nano-vectors for applications such as the delivery of drugs to solid
tumors. We begin with a review of the application of nanotechnology in cancer,
summarized from various different sources.
1.3 Cancer Nanotechnology
1.3.1 Nanotechnology
Nanotechnology refers to the creation and utilization of materials, devices, and
system through the control of matter on the nanometer-length scale. Formal
definitions require that the functional structures created have at least one
characteristic dimension measured in the 1 - 100nm range. Nonetheless, in
Whitesides' definition of nanotechnology 8, he describes the 'right' size in
nanobiotechnology in an operational sense, with respect to addressable unmet
needs in biology, rather than placing stringent limitations on the exact
12
dimensions. Others, including Langer and colleagues have also taken a similar
standpoint, the former in the context of drug-delivery applications9.
In the context of biological systems, nanotechnology offers the ability to control
the size of the resulting particles and devices. Figure 1 provides a comparison of
the size of certain popular nanoparticles, including liposomes, dendrimers, gold
nanoshells, quantum dots and fullerenes to familiar items. The diameter of
human cells span 10 - 20 pm while the size of cell organelles ranges from a few
nanometers to a few hundred nanometers. Typically, nanoscale constructs and
devices are smaller than human and around the same size as large biological
macromolecules such as enzymes and receptors10 . These nanoparticles provide a
less invasive method of interacting with biomolecules both on the cell surface
and within the cells, without altering the behavior and biochemical properties of
those molecules3.
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Figure 1. Size of nanoparticles compared to bioloqical entities and other familiar items (Source:
McNeil )
For drug delivery applications, nanoparticles must be small enough to avoid
rapid filtration by the spleen, with filaments spaced roughly 200 nm'1 , that form
a meshwork for phagocytic cells 12. Furthermore, the nanoparticles need to be
small enough to pass through the liver's fenestrate (150 - 200 nm) and avoid the
Kupffer cell-lined sieve plates13. Despite their small size, the capacity, or payload
of nanoparticles is on the order of tens of thousands of atoms or small molecules.
1.3.2 Targeting strategies
Targeting strategies for nanoscale drug delivery systems can be divided in to two
categories. Passive targeting takes advantage of certain unique features of the
14
tumor and its microenvironment for the selective delivery of agents to the tumor
vasculature or cells. On the other hand, active targeting involves conjugating
targeting components to nanoparticles in order to achieve preferential
accumulation of nanoparticles at the tumor site.
Solid tumors have a diffusion-limited maximal size of about 2 mm3 14,15
Angiogenesis enables tumor growth by granting them access to the circulation,
but rapid vascularization to serve fast-growing cancerous tissues tends to result
in leaky, defective architecture and impaired lymphatic drainage 16. Matsumura et
al.17 first described an enhanced permeation and retention (EPR) effect due to this
structure that allows nanoparticles to accumulate at the tumor site. Our group
has previously established a relationship between probe size and tumor vessel
permeability for relatively small macromolecules (3 - 10 nm) as well as estimated
the pore cutoff size of the vessel wall to relatively large particles (100 - 2000
nm)18,19. EPR is a selective strategy that is now used in the clinic for particle-
mediated delivery by liposomes6 ,20. For this passive targeting mechanism to
work, the size and surface properties of the nanoparticles must be controlled to
avoid uptake by the reticuloendothelial system (RES)21.
It is now well known that a hydrophilic polymer coating, such as polyethylene
glycol (PEG) increases circulation times of the nanoparticles, believed to result
from decreased opsonization and subsequent clearance by macrophages in
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addition to preventing plasma protein adsorption 22. Our group and others have
also demonstrated that cationic surface charge facilitates the accumulation of
liposomes in the tumor vasculature23-25 .
Instead of relying on the EPR phenomenon, another method is the direct local
delivery of anticancer agents to tumors. While this strategy is desirable because it
circumvents the systemic circulation, direct administration is highly invasive as
it involves injections and surgical procedures. In addition, some tumors, such as
lung cancers, are difficult to access.
An alternative targeting strategy is to conjugate active recognition moieties to the
surface of a nanoparticle. These targeting moieties provide preferential
accumulation of nanoparticles in the tumor-bearing organ, tumor interstitium,
individual cancer cells, intracellular organelles or specific molecules in cancer
cells 3. Employing molecularly targeted nanoparticles has several advantages
over conventional antibody-guided therapy, including delivery of significantly
greater therapeutic payloads per target biorecognition event, enhanced
selectivity by carrying a cocktail of targeting agents, ability to integrate means to
bypass biological barriers as well as the colocalized delivery of multiple agents,
resulting in targeted combination therapy 2.
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Although these targeting strategies are effective by themselves, synergistic
combinations of these strategies will possibly achieve the greatest gain in
therapeutic selectivity2 . In the future, nanoscale vectors should serve as
customizable, targeted drug-delivery vehicles capable of carrying large doses of
anticancer agents into malignant cells while sparing healthy cells, thus reducing
the damaging systemic responses to these drugs.
1.3.3 Quantum Dots
We now turn our focus to quantum dots (QDs) - colloidal semiconductor
nanocrystals with unique photochemical and photophysical properties 26. QDs
used in biological imaging consist of an inorganic core, typically CdSe, that is the
optically active center, an inorganic protective shell, typically ZnS, and an
organic coating designed for biological compatibility and further conjugation
(Figure 2). The cores are nearly spherical semiconductor nanoparticles, ranging
from 2 - 10 nm in diameter.
17
Optically active core
Protective Inorganic shell
Organaic cap
Functionalized envd group
Figure 2. Schematic of a QD showing an optically active core, a protective inorganic shell an
organic cap and one of the organic cap molecules functionalized.
These nanoparticles have several desirable properties that make them ideal for
this study: they are several orders of magnitude brighter than conventional
fluorophores, photostable, tunable to a desired narrow emission spectrum and
relatively insensitive to the wavelength of excitation light27. Figure 3 shows the
excitation and emission spectra for QDs of various colors.
1.0
0.8-
0.6-
0.4-
0.2-
0.0 ,,400 500 600 700
Emission Wavelength (nm)
b
C
1.0-
0.2
0.0
750 800 850 900 950
Excitation Wavelength (nm)
Figure 3. Quantum dot spectra. (a) QDs tuned to emit at wavelenghts not shared by signals from
GFP and second harmonic generation with 810-nm incident light (green and dark blue lines,
respectively). QDs exhibit a narrow and symmetric emission spectra (cyan, yellow and red lines).
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(b) QDs have broad excitation spectra, as seen in the relatively broader two-photon action cross
sections (cyan, orange and red lines) compared to cascade blue (dark blue line)
Robust water-soluble QDs have been created for biological applications such as
multiphoton fluorescence imaging in live animals 2 7,28. QDs have also been
customized to distinguish multiple cellular components within the tumor milieu
in vivo and to measure the ability of particles of different sizes to access the
tumor28. Similarly, single particle tracking using a QD conjugated with tumor-
targeting antibody has been performed to gain more insight on the interactions
and processes involved in the transport of drug carriers in living mice2 9 .
Because QDs permit in vivo imaging at different length scales, it is also possible
to image entire structures using QDs. Near infrared QDs have been successfully
used to map lymphatic drainage and sentinel lymph nodes in mice and pigs30,31.
Likewise, the macroscopic distribution in vivo of QDs can also be determined for
studies on nonspecific uptake32.
1.4 Tumor Interstitium
1.4.1 Barriers to Drug Delivery
19
In order to improve the delivery of therapeutics to solid tumors, it is crucial to
understand the barriers to drug delivery and effectiveness. The first barrier any
nanoparticle injected into the blood stream encounters is the chaotic blood
supply of a tumor5 . Unlike normal blood vessels, tumor blood flow is temporally
and spatially heterogenous, resulting in compromised metabolic
microenvironments and reduces then efficacy of certain therapies. The next
barrier is the vessel wall, which is generally more permeable in tumors than in
host tissues, but extremely heterogenous in permeability. Thus, nonuniform
extravasation of nanoparticles occurs, leading to a spatial distribution that is
heterogenous in the tumor.
Upon extravasation, the nanoparticles then face the challenge of moving through
the interstitial space to reach the cancer cells. Transport of nanoparticles within
the tumor interstitium depends on their size, charge and configuration, as well as
the physico-chemical properties of the interstitium itself. The interstitium, is the
third barrier and the focus of the remaining sections, which provides a summary
of the tumor interstitial properties.
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1.4.2 Composition of Tumor Interstitium
The interstitium is defined as the space located between the blood vessel wall
and the cells. The basic structure of the interstitial space is similar in all tissue
and is composed predominantly of a collagen fiber framework that contains a
hydrophilic gel phase made up of glycosaminoglycans, a salt solution and
plasma proteins33. The concentrations of collagen and hyaluronan (HA) content
in human and murine tumors grown in mouse dorsal chambers measured by
Netti et al.34 are shown in Table 1. In general, the tumor interstitium is
characterized by large interstitial space, high collagen concentration and low
preteoglycan and HA concentrations 35. Since the work of Gersh and Catchpole36,
the interstitium is often viewed as a two-phase system with a colloid-rich gel
phase containing the hydrophilic hyaluronan (HA) and proteoglycans and a
colloid-poor free fluid phase.
Table 1. Collagen and hyaluronan (HA) content in the interstitial matrix (IM) of human and murine
tumors
Tumor Type Collagen Content HA Content
(mg/ml IM) (mg/ml IM)
MCalV (Mammary carcinoma) 9.0 ± 2.5 0.80 ± 0.15
LS174T (Human colon adenocarcinoma) 9.0 ± 2.5 0.55 ± 0.10
U87 (Human glioblastoma) 44.5 ± 21 0.55 ± 0.15
HSTS26T (Human soft tissue sarcoma) 29 ± 5.5 0.80 ± 0.10
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1.4.2.1 Collagen and Elastin
The basic structural unit of the collagenous fibers is the collagen molecule
(diameter, -1.5 nm; length, -300nm; molecular weight, -285,000 kDa), formerly
called tropocollagen35 . The collagen molecule consists of three helical
polypeptide chains (molecular weight, -95,000 kDa) that are supercoiled to form
a ropelike structure of great strength. At present, eleven different types of
collagen are known and there may also be differences in the way the three
polypeptide chains are assembled within each type. Nonetheless, each type has
similar structure as a result of a repeating amino acid triplet, with every third
amino acid being glycine 37.
Collagen is secreted from fibroblasts and the assembly of collagen molecules to
form fibrils and subsequently fibers takes place extracellularly. Tumor collagen is
produced by the host and its synthesis is governed by the tumor cells 38. Not
much is known about the control of thickness and orientation of collagen fibers,
but it appears to be influenced by the presence of glycosaminoglycans 39,40. Like
other structural components of the interstitium, elastic fibers also have excluding
properties. Nonetheless, since the elastin content in skin is only -2% of wet
weight 4l, the absolute contribution from the elastic fibers to the total interstitial
exclusion is small. Thus far, no attempt has been made to quantify the elastic
fiber content of tumors.
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1.4.2.2 Glycosaminoglycans
Glycosaminoglycans (GAG) are polyanionic polysaccharide chains of variable
length made from repeating disaccharide units37. The disaccharide units have
anionic groups (carboxylate-, sulfate ester- and sulfamino- groups) that are fully
charged at physiological pH. Mutual repulsion of negative charges on the chains
results in swelling in solution35 . With the exception of hyaluronan, the seven
subfamilies of GAG are bound covalently to a protein backbone and are known
as proteoglycans33. Presently, data on proteoglycan content in tumors are
limited 35 .
Hyaluronan (HA, also called hyaluronic acid or hyaluronate) is a high molecular
weight GAG (several million kDa) that is synthesized at and extruded through
the plasma membranes of fibroblasts42. While the proteoglycans are immobilized
in the interstitium, HA has not been shown to be immobilized 43. HA is highly
hydrophilic and each glucuronic acid unit contains one carboxyl group, giving
rise to HA's polyanionic character at physiological pH4 4 . In water, HA molecules
can expand in volume up to 1000 times and form loose hydrated matrices. Thus,
HA is thought to act as a space filler, lubricant and osmotic buffer45 .
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1.4.3 Electrical Charge
As mentioned earlier, the GAG are negatively charged at physiological pH due
to the substituted side groups on the sugar molecules, with one to three negative
charges on each dissacharide unit. In the case of HA, Comper and Laurent
measured a charge of -1 mol/mol HA-dissacharide unit (molecular weigh, 386
Da)46. On the other hand, collagen has a net positive charge at physiological pH.
Li and Katz measured a charge of +14 mol/mol in reconstituted collagen 47. The
charge on collagen is less than that for HA on a molar basis, but could be of
importance due to the large amount of collagen in the tumor interstitium.
Overall, Wiig et al. suggested that the tumor interstitium acts as a negatively
charged matrix48. The additional content of anionic proteoglycans perhaps causes
the net negative interstitial charge observed.
1.4.4 Interstitial volume exclusion
The tumor interstitium is a crowded microenvironment and the presence of
collagen and GAG limits the space accessible by plasma proteins and other
macromolecules, a phenomenon called volume exclusion 49. The main part of
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exclusion has been attributed to the intrafibrillar space and the abundant
collagen 0, but GAGs are also responsible for exclusion. In particular, HA, which
has a very high exclusion per gram because of its random coil structure. The
volume excluded per unit weight of native collagen has been estimated at 4 ml/g
compared with 40 ml/g for HA4 6,51. The magnitude of the excluded volume has
important consequences in the dynamics of transcapillary exchange.
Furthermore, the presence of charged matrix components that are markedly
increased during tumor development (such as HA) could potentially influence
even further the tissue distribution of charged macromolecules via electrostatic
repulsion forces48.
1.4.5 Interstitial Transport
Transport of macromolecules within the tumor interstitium depends on their
size, charge and configuration, as well as the physico-chemical properties of the
interstitium itself. Since the interstitial fluid pressure in solid tumors is uniformly
elevated, convection in the tumor interstitium is negligible5 2 and the movement
of macromolecules in the extracellular matrix (ECM) relies on passive diffusive
transport 3.
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1.4.5.1 Dependence on size, configuration charge and binding
Compared to normal tissue, the transport of macromolecules in tumor tissue is
hindered to a lesser extent5 4, which is consistent with reduced contents of GAGs
and significantly larger interstitial spaces in tumors55. The effect of
size/molecular weight on the diffusion of macromolecules in the tumor
interstitium has been studied extensively 4 0,54 ,56,57 and interstitial diffusion has
been shown to decrease with increasing molecular size. The effect of molecular
configuration on diffusion in agarose gels58 and microporous membranes 9 has
also been investigated by comparing tracers with linear and globular
configurations. Flexible macromolecules exhibited greater mobility in the gel
than comparable-size rigid spherical particles, possibly due to trapping of the
rigid particles in gel pores.
On the other hand, the effect of surface charge of macromolecules on their
interstitial diffusion has not been studied extensively. In studies using charged
agarose gels, Johnson et al.60 reported that there were no effects of ionic strength
on bovine serum albumin (BSA) diffusivities, but with smaller proteins there was
a decrease in diffusivity at lowest ionic strength. Nugent et al.54 found diffusive
transport of BSA in the rat mesentery to be hindered more than dextran of same
molecular size. Such a deviation could be explained by a smaller effective
volume for diffusion due to electrostatic repulsion of negatively charged
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albumin, in terms of configuration, or by the binding of BSA to tissue
components. Thus, the effect of charge alone needs to be assessed in order to gain
a better understanding.
1.4.5.2 Role of collagen and GAG
Diffusion of large molecules in tumors has been correlated to collagen content
and organization, but not to HA content 4 ,40 . Specifically, collagen type I and its
organization into fibrils is reported to play a significant role in limiting the
diffusion of macromolecules. The narrow spacing between collagen fibrils (20-
40nm) will exclude or hinder the migration of larger particles40. Nevertheless,
Ramanujan et al.61 suggested that unassembled collagen also plays a role in
hindering diffusion after performing studies with collagen type I gels.
The alignment and spacing of collagen is modulated by proteoglycans 40.
However, it has yet to be determined if the interaction between proteoglycans
and fibrillar collagen limits the diffusion of macromolecules in the interstitium.
Similarly, the effect of HA on the diffusion of macromolecules is yet to be
determined. HA solutions at concentrations comparable to several tumor types
were shown to pose a weaker barrier to diffusion compared to that of collagen.
Because hyaluronidase decreases diffusion of IgG in tumors57, it is also possible
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that the swelling potential of intact HA increases the pore size between ECM
molecules and actually facilitates diffusion.
1.5 Conclusion
Nanotechnology is an emerging field that will potentially result in significant
advances in early detection, molecular imaging, assessment of therapeutic
efficacy, targeted and multifunctional therapeutics as well as the prevention and
control of cancer. Despite the promise of nanotechnology for a bright future,
nanosized hybrid therapeutics and drug delivery systems will not be
advantageous unless they reach the desired target in effective concentrations. In
general, the tumor interstitium is characterized by large interstitial space, high
collagen concentration and low proteoglycan and HA concentrations.
Modification of the net charge of a nanoscale vector in order to assess its effect on
transport in tumors is an important investigative tool in cancer therapy.
Recently, a powerful technique - fluorescence correlation spectroscopy (FCS)
was optimized for in vivo measurements of diffusion of macromolecules in
tumors and revealed the two-phase nature of transport 7. The emergence of FCS
as a new and highly sensitive method to probe interstitial transport parameters
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could potentially shed new light on our understanding of the transport
phenomena in the tumor interstitium.
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Chapter 2: Fluorescence Correlation
Spectroscopy
2.1 Introduction
Fluorescence correlation spectroscopy (FCS) is an experimental technique that
uses statistical analysis of the fluctuations of fluorescence in a system in order to
study kinetic processes. FCS was first introduced more than 30 years ago to
measure diffusion and chemical kinetics of DNA-drug intercalation 62,63. This
extremely powerful and sensitive technique has since been applied to measure
translational diffusion, rotational diffusion, flow and chemical reactions 63-66.
Even when a system is at equilibrium, its components are continually fluctuating
about their thermodynamic mean concentration. If the observed region of the
solution is open, these fluctuations are caused by random variations in the
number of molecules that enter or leave the region by diffusion and by the
molecules that are formed or eliminated by chemical reactions. Observation of
these spontaneous fluctuations can yield a complete kinetic description of the
system6 3. In order to measure the number of molecules of a specific type in a
defined open volume of solution as a function of time, the molecules can be
fluorescently labeled and their emitted fluorescence intensity, which is
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proportional to the number of fluorescing molecules in the illuminated region, is
monitored over time. If the number of molecules in the illuminated volume is
small enough, fluorescence fluctuations due to the diffusion of molecules in and
out of the volume becomes measurable. It is not possible to determine diffusion
coefficients accurately from the time courses of single stochastic fluctuations, so a
large number of fluctuations need to be measured and analyzed statistically 67.
The fluctuations can be quantified in their strength and duration by temporally
autocorrelating the recorded intensity signal, providing a measure of self-
similarity of the intensity signal and thus describing the persistence of
information carried by it. In other words, the fluorescence fluctuation
autocorrelation function yields the rate at which the fluctuations dissipate (rate
of relaxation of the system to equilibrium), averaged over many fluctuations68.
Early measurements suffered from poor signal-to-noise ratios, mainly due to the
low detection efficiency, large ensemble numbers and insufficient background
suppression. The basic problem was that experimentally measurable fluctuations
in fluorescence intensity occur only for very small sample volumes. For one-
photon excitation, lasers can be focused to submicron beam waists in the radial
dimensions, but there is no confinement along the beam axis. Because of such
limitations, early applications of FCS were restricted to two-dimensional
systems 69.
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However, the application of confocal microscopy techniques to FCS successfully
solved the volume problem 7 0 7 1. On the other hand, multiphoton FCS provides a
superior alternative to confocal FCS by achieving even higher signal-to-noise
ratios, reduced autofluorescence and photobleaching as well as improved
penetration in turbid media69 ,72. These advancements, coupled with the
incorporation of avalanche photodiode (APD) and photomultiplier tubes with
high photon quantum efficiency have enabled FCS studies to be conducted in
gels73, living cells 72 , and more recently, living animals 57.
2.2 Theory of FCS
FCS is performed on samples maintained at thermal equilibrium so that all of the
processes under analysis are in fact statistical fluctuations around equilibrium.
The kinetic coefficients corresponding to these processes such as diffusion
coefficients determine the dynamics of their relaxation, which in turn determines
the shape of the fluorescence fluctuation correlation curve. The presentation of
the theory of FCS in this section follows closely the line and notation of Schwille
and Haustein 74 with some minor modifications introduced.
The normalized fluorescence fluctuation autocorrelation function is defined as:
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G(r)= (8F(t)3F(t±2 v)(
(F(t))
where SF(t) represents the fluorescence fluctuations resulting from whatever
process is occurring in an open ensemble of molecules of an average
concentration (C)in a detection volume V, illuminated by focused laser light.
The fluorescence emitted by the molecules in the focal spot is recorded photon-
by-photon and assuming constant excitation power, the fluctuations of the
fluorescence signal are defined as deviations from the temporal average signal:
,F(t) F(t) - (F(t)) (2)
lT
(F(t)= JF(t)dt (3)
If all fluctuations arise only from changes in the local concentration within the
effective volume of the focal spot, the variations can be written as:
6F(t) = K(Io) j S(r) Q(r) 5(uqC(r, t)) dV (4)
V
In the above equation, K represents the overall detection efficiency of the optical
system comprising of collection optics, filters and detectors, q is the fluorescence
quantum yield of the dye, o is the molecular absorption cross-section, and C
denotes the local particle concentration. (10) is the average intensity at the
geometrical focal point and S(r) is the dimensionless spatial distribution
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function of the focused light in the sample space. Q(r) is the collection efficiency
function weighting factor for confocal optics.
To simplify equation 4, the convolution factor of the two dimensionless spatial
optical transfer functions can be combined into a single function,
W(r) = S(r) * Q(r) which describes the spatial distribution of the emitted light.
W(r) can be approximated as a three-dimensional Gaussian, which is decayed to
e at r. in the lateral direction and at z0 in the axial direction.
W(r)= e r( e z2 (5)
The remaining parameters (I,), -, K and q can be combined into a parameter, 77,
that describes the photon count rate per detected molecule per second. This
parameter is also used as a measure for the signal-to-noise ratio of the
measurement.
17= KIo0)uq (6)
Substituting (5) and (6) into (2), we now have:
SF(t)= JW (r) 6(7C(r,t)) dV (7)
V
Now we insert (7) into (1) to obtain:
JJ W (r)W (r') (( 7C(r, t))3( 7C(r' ,t + 7))) dV dV'
G(T)= 2 (8)
fW (r)( 9(yC(r, t))) dV)
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The fluctuation term 8(qC(r, t)) = C -r+ 7SC can be simplified assuming the
chromophore's fluorescence properties are not changing within the observation
time, i.e. , S 7 =0 , resulting in:
G(r) =
JJ W (r)W (r') (S(C(r,o))i(C(r', r))) dV dV'
((C) JW(r) dV
(9)
If we only consider particles that are freely diffusing in three dimensions with
the diffusion coefficient D, the number density autocorrelation term can be
calculated:
(10)(K (C(r,O))S(C(r', r))) = (C) (4 irD -r)2 e 4Dr
Inserting (10) into (9) yields:
G(r) =
W (r W 
(e- r)21 JJ ~)W(r')e- 4Dr
(C) (47_Dr) 2
dV dV' (11)
(fW(r) dV)
Finally, substituting (5) into (11) results in the expression for the normalized
three-dimensional diffusion autocorrelation function for one
molecules:
Z7~
1+±
In the above equation, Vf is defined as the effective focal volume:
2 e e .0dV
f W (r) dV) JeX3 2
WV2 (r) dV -4 ( +7, 21 -4 fz0Je e
G(r) v+(C)(1+
species of
(12)
(13)
35
dV
rz, the average lateral diffusion time for a molecule with diffusion coefficient D
through the effective measurement volume element Vf is defined as:
2
D- r.(14)4D
From equation (12) we can see that it is possible to determine the local
concentration of fluorescent molecules from the amplitude of the autocorrelation
curve, G(O):
G(O) (15)Vff(C) (N)
Because the amplitude of the autocorrelation function is inversely proportional
to the average number of molecules in the focal volume, it is important to
minimize the concentration of fluorescent molecules to obtain a better correlation
signal. Typically, the temporal average of the particle number should be between
0.1 and 1000, which corresponds to concentrations between sub-nanomolar (<10-9
M) and micromolar (10-6 M) for a focal volume around one femtoliter.
Alternatively, decreasing the size of the focal volume can increase the amplitude.
2.3 Multiphoton FCS (MPFCS)
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In this thesis, the term muliphoton excitation (MPE) refers primarily to a two-
photon excitation (TPE) event. The advantage MPE offers to FCS is the natural
3D localization of the excitation volume inherent in nonlinear excitation. In the
case of TPE, the intensity-squared dependence is the basis of the localized nature
of two-photon excitation: doubling the intensity produces four times the
fluorescence 75.
Using a three-dimensional Gaussian function to describe the dimensions of the
MPE focal volume allows for derivation of simple analytic expressions for the
lateral l/e radius co)y as well as the axial l/e radius, co75.
0.322A.
TNA NAO7(16)
xy, = O.3252L16
KY 0 .32 5 N A > 0 .7
-v2 NA 0.-91
O.5322Ln0532Aj (17)
_m _n, - n - NA
where m is the excitation order (e.g., m=2 for TPE) and n, is the index of
refraction of the immersion media. Conversion to 1/e 2 radii, ro and z0, can be
obtained by multiplication by ATh.
The equations in this section only hold true for diffraction-limited optics. This
refers to when the objective lens entrance pupil (back aperture) is overfilled. In
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practice, this requires that the l/e diameter of the beam be at least equal to the
entrance of the pupil diameter 76.
For MPFCS, several changes need to be made to equations 13 and 14. Integrating
the three-dimensional Gaussian yields 72,75 :
(18)V I, = XY t> z = (5)ro zo
The above volume approximation is 0.68 of the value calculated by numerical
integration of the two-photon illumination spread function 77, so equation 18
should be further multiplied by 1.47 for the best approximation of the effective
excitation volume.
The average lateral diffusion time for MPFCS, rD, is also slightly different due to
the introduction of the convolution factor as a squared instead of a simple
Gaussian72 .
2
8D
(19)
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Chapter 3: Instrumentation Development for
Multiphoton Fluorescence Correlation
Spectroscopy
3.1 Introduction
The previous chapter described in detail the theory of FCS and the advantages of
multiphoton excitation (MPE). Here, we describe the experimental realization of
MPFCS. Our setup was designed to enable diffusion measurements of
nanoparticles to be carried out in gel models of the tumor interstitium as well as
in live animals.
MPFCS can be implemented using the same scheme for two-photon laser
scanning microscopy invented by Denk 78 et al. By integrating MPFCS with our
home-built multiphoton laser scanning microscope (MPLSM), the specimen can
be imaged with the same illumination and excitation optics. Thus, we can image
the nanoparticle distribution, examine collagen structure and content, as well as
measure the diffusion coefficients of the nanoparticles.
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3.2 Experimental realization of MPFCS
3.2.1 Optical and hardware setup
In our setup (Figure 4), pulsed laser light from a Mai Tai femto-second titanium-
sapphire (Ti:S) laser (Spectra Physics) is first expanded by a factor of 2 in order to
overfill the back aperture of a high power objective that is used to focus the light
inside the sample. The X-Y scanner (a modified Fluoview scanhead BX61W1
from Olympus) allows images of the sample to be taken and once a spot is
chosen for diffusion measurements, the laser beam is parked at the desired
location. Since the probability of a two-photon event is extremely low, all of the
absorption occurs only in a small region near the focus where the energy density
is the highest. Fluorescence emission from the excitation volume is focused into a
GaAsP photomultiplier tube (PMT) after passing through a bandpass filter to
select the emission spectra of interest. Fluctuations in fluorescence intensity are
recorded as fluctuations in the photocurrent of the PMT exposed to fluorescent
radiation and a digital correlator card performs autocorrelation of the
fluorescence intensity signal. The resulting autocorrelation curve is displayed on
a computer that allows control of data acquisition time and analysis of the
autocorrelation curves.
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Since photon counting is required for FCS, detectors with high quantum
efficiencies must be used. Avalanche photodiodes are commonly used in FCS
setups because of their high quantum efficiencies, but the small active area of an
APD makes alignment more difficult then necessary. As an alternative, the
detector we chose to use is a GaAsP PMT (Hamamatsu H7421-40) that has a
spectral response from 300 - 720 nm, a 5x5 mm active area and about 42%
quantum efficiency at 550 nm.
ITlS lisp
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Figure 4. Optical setup for MPFCS measurements. Laser light (red) is expanded, collimated and
focused by a high power objective inside the sample. Fluorescence (green) emitted by excited
molecules within the two-photon excitation volume is collected and focused into a PMT with
single-photon sensitivity.
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For the best collection of fluorescence, it is also important to use high power
objectives with larger numerical apertures (NAs). Originally, a Olympus 20x 0.95
NA water immersion lens was selected because of its high NA and wide field of
view. However, the expanded laser beam diameter was limited by the size of the
X-Y scan mirrors and could not overfill the large back aperture of this particular
lens (17 mm). Thus, FCS measurements were carried out using an Olympus 63x
1.2 NA water immersion lens instead.
Autocorrelation curves were generated using a digital correlator card in order to
provide almost real-time visualization of the quality of the FCS measurements.
The USB based hardware correlator (Flex 012-12D, Correlator.com) continuously
counts the number of photons in a short time period and increments the lag time
in the autocorrelation calculation in a logarithmic fashion in order to cover
several orders of magnitude (nanoseconds to a few seconds).
3.2.2 Software for data analysis
In order to extract information from the autocorrelation curves, we developed
software to analyze the raw data and perform data fitting in MATLAB. First, the
software extracts the intensity history and correlation functions from the output
of the digital correlator card and stores them in vectors. Using a nonlinear least
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squares fitting routine, the correlation functions are then fitted to a model
specified by the user. Available models include single component free diffusion,
multicomponent free diffusion (2 - 3 components), anomalous diffusion and
anisotropic diffusion. In addition, models that accounted for triplet state kinetics
were also included. For all models, the values for ro and K were fixed, with the
exception of a calibration model for focal volume size determination. Users also
can specify upper and lower bounds to the free parameters in order to improve
the resulting fits by including more information. Upon completion of a fit, the
software then plots the experimental data and resulting fit on a graph as well as
returns the fit parameters along with the goodness of fit measurements.
As the amount of data to process increased, the software was also improved to
allow for batch processing. An entire dataset can be analyzed and the extracted
fit values are exported as a text file while the set of figures are exported as a
postscript file.
3.3 Calibration of MPFCS system
3.3.1 Testing the digital correlator card
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One of the first components to be tested was the Flex012-B digital correlator card.
In order to do so, a function generator was used to provide periodic input signals
of various frequencies. The output of the digital correlator when square waves
and sine waves of different frequencies were applied showed peaks at the
respective periods of the input signal. This is exactly what we expect since
periodic signals will produce peaks in their autocorrelation function when the
overlap is maximum, i.e. at every time period. Thus, we confirmed that the
digital correlator card was indeed working.
Autocorrelation function of 5Vpp square wave 1 kHz Autocorrelation function of EVpp square wave 2.5 kHz
10'3 10- 10'1
c(s)
f= 1 kHz, T= le-3 s
Autacorrelation function of 6Vpp sine wave 70) kHz
-ofCo
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f = 700 kHz, T = 1.43e-6 s f = 80 kHz, T = 1.25e-5 s
Figure 5. Testing the digital correlator card. Square waves and sine waves with 5V peak-to-peak
voltages were generated at different frequencies and the output of the correlator card recorded.
The autocorrelation curves produced show peaks at every time period, T, corresponding to the
frequency, f, of the input signal.
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3.3.2 Measurement of laser power at sample
The relationship between the laser power measured before entering the X-Y
scanbox and at the sample was examined for the 60x, 1.2 NA objective
(Olympus). From Figure 6, we see that the laser power at the sample is around 7
times less than the laser power measured before entering the scanbox. This can
be attributed to the power loss at the lenses and mirrors, as well as the objective
lens.
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Figure 6. Relationship between laser power before X-Y scanbox and laser power at sample.
Laser power at the two locations were measured for 4 different settings (red diamonds) and a
linear best fit line (blue line) yields the relationship between the two.
3.3.3 Testing the stability of MPFCS setup
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Because FCS is such a sensitive technique, the stability of the optical setup is very
important to ensure accurate measurements. To minimize the effect of floor
vibrations, the MPFCS setup was built on a vibration isolation optical tabletop. In
addition, the X-Y scanner has to be stable so that when the laser is parked, it will
not introduce artifacts into the data due to the residual motion or vibration of the
galvanometers.
To test for our system's stability, we performed FCS measurements of
fluorescently labeled beads stuck on a microscope slide. Autocorrelation curves
of green fluorescent microspheres (1 pm diameter, Polysciences Inc.) and red
fluoresecent microspheres (Polymer microspheres, 0.25 pm diameter, Invitrogen)
dried on slides are shown in Figure 7.
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Figure 7. Test for stability of MPFCS system. Autocorrelation curves of 1 pm (yellow-green) and
0.28 pm (red) fluorescent microspheres stuck on a microscope slide display a flat profile. FCS
measurements were performed at 800nm excitation and with 2.9 mW laser power at sample.
Since there is no movement of the fluorescent microspheres in and out of the
excitation volume, there is no correlation function (flat profile). Fluctuations in
fluorescence intensity in this situation are due mainly to shot noise which is
random and does not produce a correlation, since fluctuations at different time
intervals are not correlated. If there were others sources of non-random
fluctuations, correlation would be present in the curves shown above.
3.3.4 Characterization of the excitation volume
The effective focal volume, Veff and the 1/e 2 values in the lateral (r) and axial
(zO) direction can be estimated experimentally by calibration of the system with a
dye of known dynamic properties. The data analysis is slightly different when
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characterizing the focal volume. Instead of having the diffusion coefficient, D, set
as a free variable, D is fixed to a known value while r and the aspect ratio, K are
allowed to vary freely.
The objective characterize was an Olympus 60x (1.2 NA) water immersion lens
with a correction collar. Since it has been suggested that the correction collar can
eliminate spherical aberrations for a wide range of beam collimations to yield an
asymptotic minimum focal volume79, we perform an experiment varying the
correction collar setting for each FCS measurement to determine its effect on the
focal volume (Figure 8).
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Figure 8. Effect of correction collar setting on autocorrelation functions. FCS measurements were
performed on fluorescent microspheres in solution at 800 nm excitation with constant laser power
at the sample (2.9 mW) and different correction collar settings.
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It is clear that the amplitude of the autocorrelation functions, G(O), decreases as
the correction collar setting increases. From equation (15), we know that G(O) is
inversely proportional to the effective focal volume. Thus, we can use the inverse
of G(O) as an indicator of the focal volume size to find the optimum collar setting
(Figure 9).
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Figure 9. Relationship between focal volume size and correction collar setting. The focal volume
size increases as collar setting increases and its minimum value is around 0.14.
Since the focal volume size increased with higher correction collar setting, the
laser beam in our system could be slightly diverging79 and not perfectly
collimated. In any case, the optimum collar setting was 0.14 to achieve the
minimum focal volume and was fixed for all remaining experiments.
We chose to use a sample of red fluorescent microspheres (Duke Scientific) in
with a mean hydrodynamic diameter of 0.28 pm to characterize the focal volume
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of our MPFCS system. For a spherical particle of radius r, its diffusion coefficient
can be calculated using the Stokes-Einstein equation:
k TD= B (20)
In the equation above, kB represents the Boltzmann's constant, T is absolute
temperature and q; is the viscosity of the medium. Thus, using equation (20), we
estimated the diffusion coefficient of the 0.28 pam microsphere to be 1.7507 x 10-7
cm 2/s in water at room temperature. With this information, analysis of FCS
measurements of the microspheres in solution (Figure 10) yielded ro = 0.36 pm
and K =5.
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Figure 10. Calibration of focal volume size. FCS measurements (blue circles) were performed on
a sample of 0.28 pm microspheres in distilled water at 800 nm excitation and 2.9 mW laser power
at the sample. A total of five measurements were performed (each 60s long) and averaged before
fitting (red line) for ro and K with D fixed at 1.7507x1 07 cm2 /s.
Typically, rhodamine-6G is used for calibration because it has a well know
diffusion coefficient of 2.8 x 10-6 cm 2/s in solution at room temperature62.
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However, measurements are not easily obtained because the size of rhodamine-
6G approaches the resolution limit of our MPFCS system and the laser power at
the sample needs to be very low (< 3 mW) to avoid saturating or photobleaching
the dye. Furthermore, since rhodamine-6G sticks to the walls of the slide and to
the bottom of the coverslip, the slides and coverslips must be coated with
nonfluorescent BSA prior to sample preparation. Using our estimated values of
r and K, measurements of rhodamine-6G (Figure 11) yielded D = 2.721 x 10-6
cm 2 /s, which is in good agreement with literature.
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Figure 11. Diffusion of rhodamine-6G in solution. FCS measurements (green circles) were
performed on nM concentration of rhodamine-6G in distilled water at 800 nm excitation and 2.9
mW laser power at the sample. A total of ten measurements (each 120s long) were performed
and averaged before fitting (red line) to yield D = 2.721 x 10-6 cm2/s.
Theoretical estimates of the focal volume produced by a 1.2 NA objective with
800 nm excitation light using equations (16) and (17) yield r, = 0.22 pam and K =
2.6 , which is significantly smaller than the values determined experimentally.
These values are unreliable because Gaussian beam theory assumes uniform
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overfill of the back aperture and perfect beam collimation, which in practice, is
extremely difficult to achieve. In addition, high NA objectives may not have ideal
modulation transfer functions from manufacturing due to strong attenuation of
marginal rays80.
3.3.5 FCS measurements in solution
Further calibration of the MPFCS system was performed by measuring the
diffusion of size series of microspheres (Polysciences, Inc.) in solution. For each
size, the theoretical diffusion coefficient was calculated using equation (20) and
compared to the values obtained by FCS (Figure 12). Our measurements matched
the predictions by the Stokes-Einstein equation very closely, demonstrating the
accuracy of our system.
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Figure 12. FCS performed on a size series of microspheres. Diffusion measurements (red
triangles) were performed for microspheres of different sizes (44, 51, 71, 100 nm) in distilled
water at 800 nm excitation and 3.6 mW laser power at the sample. Ten measurements (each 15
- 60s) were performed for each different microsphere. Theoretical values (purple diamond) are
shown for comparison.
We also measured the diffusion of tetramethylrhodamine-conjugated albumin
(TAMRA-BSA) using our system. Once again, the value we obtained (D = 6.462 x
10-7 cm 2/s) agreed with literature value of 6.4 x 10-7 cm 2/s 81.
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Figure 13. Diffusion of albumin in solution. FCS measurements (green circles) were performed
on TAMRA-BSA in distilled water at 800 nm excitation and 2.9 mW laser power at the sample. A
total of ten measurements (each 120s long) were performed and averaged before fitting (red line)
to yield D = 6.462 x 10-6 cm2/s.
3.3.6 Characterization of the field of view
Finally, we characterized the field of view (FOV) for two different objective
lenses under MPE (20x Olympus 0.95 NA and 60x Olympus 1.2 NA) using a
stage micrometer (Graticules Ltd) that has 100 separate divisions with 10 ptm per
division.
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Figure 14. Field of view characterization. Images of a stage micrometer taken with an Olympus
20x 0.95 NA (left) and Olympus 60x 1.2 NA (right). Divisions are 10 pm apart. Image sizes are
1024 x 1024 pixels.
Analysis of Figure 14 showed that the FOV for the Olympus 20x 0.95 NA
objective is 630 x 630 lam and the FOV for the Olympus 60x 1.2 NA objective is
223 x 223 lam.
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Chapter 4: Fluorescence Correlation
Spectroscopy of Quantum Dots
4.1 Motivation
As highlighted in Chapter 1, the tumor interstitium is a barrier to drug delivery
and modification of the net charge of a nanoscale vector in order to assess its
effect on transport in tumors is an important investigative tool in cancer therapy.
Nonetheless, the biological complexity of the tumor interstitium makes detailed
analysis of the mechanisms of transport hindrance within the tumor difficult.
Such problems can be overcome by performing studies in gel models of the
tumor matrix as diffusion data in gels have been reported to closely match in vivo
measurements61.
In this chapter, we report the results of MPFCS diffusion measurements of
charged QD nanocrystals in collagen gels and collagen-HA composite gels. In
addition, we present MPLSM images of QD distribution and SHG images of
collagen organization inside the two gel models.
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4.2 Characterization of QDs
Our collaborators from the Bawendi Lab at MIT prepared QDs of three different
charges by modifying the surface of pre-made CdSe/CdZnS QDs with
dihydrolipoic acid (DHLA), DHLA-polyethyleneglycol (DHLA-PEG) and amino-
functionalized DHLA-PEG (DHLA-PEG-NH2). The chemical structures of these
molecules are shown in Figure 15.
DHLA DHLA-PEG DHLA-PEG-NH 2
0
OH
CrSH HS SH HS
SH HS
Figure 15. Chemical structures of molecules used to modify QD surface charges. DHLA was
selected to provide a negative charge, DHLA-PEG provides a "neutral" charge and DHLA-PEG-
NH 2 provides a positive charge.
Before any valid comparisons between the diffusion of QDs with different
surface charges can be made, it is important to characterize their
physicochemical properties. Thus, the size of the QD samples after surface
modification was measured to ensure that the three samples had similar sizes.
Measurements of the hydrodynamic radius for each QD sample were performed
using dynamic light scattering (DLS). The zeta-potential of the each different QD
sample, which is the electrostatic potential generated by the accumulation of ions
at their surface was also determined (Brookhaven ZetaPALS). The measured size
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and charge of each of the QD samples are reported in Table 2 to compare the
different modification strategies.
Table 2. Physicochemical properties of QD samples
Sapl Hyroynmi raiu (n Zeta-tnil(V
QD-DHLA-PEG-NH 2  5.83 37.39
QD-DHLA-PEG 6.2 -18.16
QD-DHLA 5.37 -31.12
The hydrodynamic radii of all three samples were similar even after surface
modification, but the zeta-potential indicated all three samples had a different
charge associated. The emission spectra of the QD samples were also measured
and the emission peak was around 640 - 650 nm.
4.3 MPFCS of QDs in solution
Before measuring the diffusion of the QDs in solution, we imaged the samples in
PBS to examine the monodispersity of each sample. For all experiments, QD
samples were passed through 0.1 pm pore size filters to remove aggregates and
diluted to final concentrations around 20 nM. Artifacts of FCS have been
reported due to blinking and saturation effects of QDs8 2, thus we investigated the
shape of QD FCS curves as a function of laser excitation power. Final FCS
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measurements for the three QD samples were obtained using the optimal power
that exhibited no artifacts and produced a good signal-to-noise ratio.
4.3.1 Results and discussion
4.3.1.1 Distribution of QDs in solution
Figure 16 depicts the distribution of three QD samples in PBS obtained by
MPLSM. The images indicate the all QD samples were uniformly distributed in
solution and did not exhibit aggregation with the exception of small
agglomerates in the QD-DHLA-PEG-NH2 sample.
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Figure 16. Images of QD-nanocrystals (Emission max: 650 nm) in phosphate buffer solution (1x
PBS) using MPLSM. The distribution of QD nanocrystals (red) modified with DHLA-PEG-NH 2 (A),
DHLA-PEG (B), and DHLA (C) are shown in PBS. Images are 223 pm across.
4.3.1.2 Curve shape variations
We found that the shape of the autocorrelation curves highly depended on the
laser excitation power, as shown in Figure 17. The decrease in G(0) as the laser
power increases is in agreement with reports in literature73,82.
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Figure 17. Typical FCS curves for QDs recorded at various
decreases visibly with increasing powers.
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One of the reasons could be due to excitation saturation of QDs, illustrated in
Figure 18. Above a certain laser intensity, the probability of exciting a fluorescent
particle at the center of the focal volume approaches unity. When the fluorescent
particle at the center are saturated, their emitted fluorescence is no longer
proportional to the laser intensity (in the case of TPE, emitted fluorescence is
proportional to intensity squared). As a result, when the laser power is further
increased, the fluorescence emission intensity from the center of the focal volume
no longer grows proportionally with the edges, leading to an effective point
spread function (PSF) that looks like a top-hat and its effective size (the full
width at half maximum, FWHM) is increased. Recalling equation (15), an
increase in Veff will result in a decrease of G(O).
-,10
to6
-1500 -1000 -500 0 500 1000
r (nm)
Figure 18. Excitation rate profile of a fluorescent particle as a function of position and laser
excitation power. As laser power is increased, the top of the Gaussian profile is clipped and starts
to look like a top-hat, thereby increasing the effective focal volume.
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Heterogeneity in QD emission properties has also been suggested and QDs have
been reported to exhibit blinking (fluorescence intermittency) 3. Since blinking
statistics of individual QDs change with excitation power, the changes in FCS
curves as a function of excitation power could also reflect modifications in
blinking parameters8 2. Nonetheless, Larson et al. found no evidence for temporal
fluctuations other than molecular diffusion when performing FCS measurements
on QDs at low excitation powers27. Thus, we chose to operate at below 0.71 mW
to reduce the possibility of QD blinking corrupting FCS measurements.
4.1.1.1 Diffusion in solution
Experimental data obtained for QDs modified with different end groups are
shown in Figure 19. Because no analytical expression to fit FCS curves can be
derived as of now, we fitted the curves with a simple single component diffusion
model (equation 12).
1.8-
QD-DHLA-PEG-NH2
1.6 - QD-DHLA-PEG
A QD-DHLA
1.4
1.2
1
0.8
0.6
0.4
0.2
0
0.01 0.1 1 10 100 1000 10000
T (ms)
Figure 19. FCS curves of QDs with different surface modifications. Experimental data was fitted
to a single component free diffusion model (red lines). At least five measurements were taken for
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each sample at laser powers between 0.4-0.7 mW at the sample. Offset between curves for
presentation purposes is 0.3.
The extracted diffusion coefficients and corresponding hydrodynamic radii are
shown in Table 3. Our results match well with the reported DLS measurements,
albeit indicating that the QDs are slightly smaller in size. Nonetheless, the
difference in diffusion coefficients between samples is not large, suggesting that
size will not be a major factor when evaluating their transport in gels.
Table 3. Diffusion coefficients and size of QD samples. The error is the standard deviation
derived from different measurements.
QD-DHLA-PEG-NH 2  4.24 ± 0.07 5.78 ± 0.11
QD-DHLA-PEG 4.38 ± 0.08 5.60 ± 0.10
QD-DHLA 5.02 ±0.15 4.89 ±0.15
4.4 MPFCS of QDs in gels
4.4.1 Methods
Collagen hydrogels were polymerized by mixing the following components in
order on ice: 97.7 pal 9.37 mg/ml acid-soluble rat tail tendon collagen (BD
Biosciences) and 2.3 ptl of sodium hydroxide (1 N). After vortexing, QD samples
were introduced and the mixture was immediately pipetted onto coverglasses
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that were subsequently sealed in petri dishes with a drop of water at the edge
(Fisher). The samples were then incubated for 1 hour at 37 'C. Final
concentration of collagen was 9.15 mg/ml.
Collagen-HA composite gels were prepared in the exact same manner with the
additional step of mixing 20 pl of 3 mg/ml hyaluronan after the collagen was
neutralized with sodium hydroxide. Final concentration of collagen was 7.63
mg/mi and HA was at 0.5 mg/ml. These concentrations closely matched the
reported values for LS174T (Table 1).
After the incubation period, coverslips containing the gel samples were sealed in
depression slides (VWR Scientific) and MPFCS measurements were performed at
room temperature. For each QD type, three gels were used to determine the
diffusion coefficient. Images of QD distribution within gels were taken with
MPLSM and the collagen structure was visualized using second harmonic
generation (SHG).
4.4.2 Results and discussion
4.4.2.1 Organization of gels
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The structure and organization of gels visualized by SHG is shown in
Figure 20.
Figure 20. Organization of gels. SHG images of collagen gels (left) and collagen-HA composite
gels (right) reveal inhomogeneous organization and short, dense fibers. Images are 223 across.
The gels appear to be isotropic and three-dimensional in nature while the
organization of collagen is poor with dense arrays of short fibers. The
inhomogeneous organization of collagen is in agreement with previous studies
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in our lab61 . The fibers in the pure collagen gel appeared to be a little denser than
those in the composite gel, possibly due to the slightly higher concentration of
collagen. Three-dimensional reconstruction confirmed the three-dimensional
nature of collagen gels (Figure 21). We did not have the resolution in our
imaging techniques to measure the average pore sizes of the gels. In addition,
since SHG only visualizes fibrillar collagen, our data does not rule out the
existence of unpolymerized collagen in what appears to be void spaces.
Figure 21. Three-dimensional rendering of collagen gel. 86 images were reconstructed, revealing
three-dimensional nature of collagen organization. Dimensions are 223 x 223 x 50 pm.
4.4.2.2 Distribution of QDs in gels
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Distribution of QDs within the network of collagen gels and collagen-HA
composite gels are shown in Figure 22 and Figure 23 respectively. In both gel
types, QD-DHLA (anionic) appeared to have form large agglomerates within the
fiber network and this is especially evident in the collagen gel (Figure 22-G) .The
presence of cationic QD-DHLA-PEG-NH 2 aggregates can also be seen in the
collagen-HA composite gels (Figure 23-A), but no large agglomerates are seen in
the collagen gels (Figure 22-A). Nonetheless, the distribution of the cationic QDs
within the collagen gels is not entirely homogenous, with what appears to be
void spaces visible. In both gel types, the distribution of neutral QD-DHLA-PEG
is uniform across the entire gel.
The significant differences in distribution for QDs of difference surface charges suggest
that the electrostatic interactions might be an important factor in determining the
distribution of nanoparticles. Electrostatic repulsion of like charges could cause QDs to
form aggregates, but it is unclear how binding due to opposite charge attaction can lead to
aggregation. The stability of surface modified QDs during the gelation phase at 37*C is
also questionable, but the difference observed between the cationic QDs in different gel
types and the homogeneous distribution of neutral QDs in both gels seem to suggest that
temperature is not the cause of the aggregation. Regardless, we can conclude that QD-
DHLA-PEG provides the best distribution across both gels. This could potentially lead to
significant improvements in drug delivery.
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Figure 22. Images of QD-nanocrystals in collagen gels using multiphoton microscopy.
Distribution of QD nanocrystals (red) modified with DHLA-PEG-NH 2 (A-C), DHLA-PEG (D-F), and
DHLA (G-1) are shown in gels composed of collagen type I fibers (green). Images are 630 pm
across.
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QD-Nanocrystals Cc
Figure 23. Images of QD-nanocrystals in collagen-HA composite gels using multiphoton
microscopy. Distribution of QD nanocrystals (red) modified with DHLA-PEG-NH 2 (A-C), DHLA-
PEG (D-F), and DHLA (G-1) are shown in gels composed of collagen type I fibers (green). Images
are 630 pm across.
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4.4.2.3 Transport of QDs in gels
QDs in both gels exhibited a photo-brightening effect in which their fluorescence
emitted increased over time when excited by a parked pulsed laser. Because of
this unusual phenomenon, FCS measurements had to be made in short time
intervals (20s) so that the intensity fluctuations had a constant mean value within
those short intervals. Furthermore, FCS measurements could not be performed
everywhere in the gels except spots with low concentration and free of
aggregation. FCS curves obtained by measuring the diffusion of QDs in both
collagen gels and collagen-HA composite gels could not be described by a single
component free diffusion equation (Error! Reference source not found.). We
fitted the experimental data to a variety of other models and found that our data
can be described in two different ways.
0.5+ Experimental data
- Single-component fit
0.4
0.3-
0.2-
0.1-
0-
0.01 0.1 1 100 1000 10000
Figure 24. Typical FCS curve of QD diffusion in gels. A 20s measurement of QD-DHLA-PEG in
collagen-HA composite gel was obtained at 800 nm excitation and with 0.7 mW laser power at
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sample. A single component free diffusion model (equation 12) produced a poor fit for the
experimental data.
0.4
* Experimental data
0.35 - Two-component fit
- Anomalous fit
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Figure 25. FCS data of QD transport in gels described by anomalous subdiffusion and two-
component free diffusion. Anomalous diffusion (purple) and two-component (red) models
provided good fits for experimental data.
The first model describes anomalous subdiffusion, a case in which diffusion is
hindered and the mean square displacement, (r2), is no longer linear but
proportional to some power of time < 1:
(r2) = 81t (21)
In the equation above, a is the temporal exponent and lies between 0 and 1, and
F is the transport coefficient of fractional time dimension. Anomalous diffusion
is simply a generalization of simple diffusion (which occurs when a = 1) and
equation 12 is modified by replacing with ,yielding:
D (an
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G(r)C= (C)+ ) + K 2 Ja)
Equation (19) now becomes:
2
a" =r
"" 817
(22)
(23)
Using the anomalous diffusion model to fit our data, we found that in both types
of gels, diffusion of all three QD samples and was hindered (a < 1) and the
anomalous diffusion exponent was between 0.4 - 0.48 (Figure 26). Since there
was no significant difference in the exponent for all samples, it is then valid to
compare the magnitude of their effective diffusion coefficients, F.
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Figure 26. Anomalous diffusion exponent (a) values of QDs in gels. Values were extracted from
experimental data fitted to an anomalous diffusion model. There was no significant difference
across all samples. cx was between 0.4 - 0.47, indicating anomalous subdiffusion. Error bars
represent 1 S.E.M.
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As can be seen in Figure 27, the transport coefficient of QD-DHLA-PEG was 70%
higher than QD-DHLA (*) and 45% higher than QD-DHLA-PEG-NH 2 (a) in
collagen-HA composite gels. Similarly, QD-DHLA-PEG had the highest
transport coefficient in the collagen gels and was 39% higher than QD-DHLA (+)
and 36% higher than QD-DHLA-PEG-NH2 (*). There was no significant
difference between the transport coefficient of QDs with the same surface
modification in the two gel types.
1.3- 1 Collagen-HA
1.1 - IMl Collagen
0.9-
U L-
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I- 0.3-
0.1
-0.1 - QD-DHLA QD-DHLA-PEG QD-DHLA-PEG-NH2
Figure 27. Transport coefficients of QDs in gels. Values were extracted from experimental data
fitted to an anomalous diffusion model. * indicates statistical significance between QD-DHLA and
QD-DHLA-PEG in collagen-HA (p < 0.05). 6 indicates statistical significance between QD-DHLA-
PEG-NH 2 and QD-DHLA-PEG in collagen-HA (p < 0.05). + indicates statistical significance
between QD-DHLA and QD-DHLA-PEG in collagen (p < 0.05). * indicates statistical significance
between QD-DHLA-PEG-NH 2 and QD-DHLA-PEG in collagen-HA (p < 0.05). Error bars represent
1 S.E.M.
Among the possible reasons for anomalous diffusion are environmental
heterogeneities, obstruction, binding interactions, or physical contrains such as
sieving, convection and percolation84 . In this case, the diffusion of QDs might be
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hindered by collagen fibers and also unassembled collagen in the void spaces of
the gels 61. The significant increase in the transport coefficient of the neutral QDs
compared to both cationic and anionic QDs in both gels suggests that
electrostatic interactions also play a role in hindering diffusion. Size alone cannot
account for this difference. Collagen gels have a net positive charge and the
introduction of HA in the composite gels introduces negative charges in the gel
matrix. Thus, the binding and electrostatic repulsion effects could significantly
reduce the transport of charged QDs, but the neutral QDs would be unaffected
by such interactions.
An alternative model that describes the experimental data is a two-component
free diffusion model, suggesting the coexistence of two populations with
different mobilities. This model has been used to describe the transport of
macromolecules in the tumor interstitium in vivo57 and provides a good fit for
our FCS curves (Figure 25). Equation can be extended to include a second
species:
G(r) = G(o) j{+ ; 1+ K_+ 2Ll+ j 1+ (24)
rD,1/ ) K 2r1- Dj 21 D,2 K2- D,2/
Here, Dand 2 represent the population fractions of each species while I-D, and
rD,2 are their respective diffusion times.
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Measurements of the population fractions of QDs in collagen-HA composite gels
(Figure 28) showed that a significantly higher percentage of QD-DHLA-PEG
traveled in the fast phase compared to QD-DHLA (*). However, there was no
statistically significant difference between QD-DHLA-PEG and QD-DHLA-PEG-
NH2.
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Figure 28. Subpopulation fraction of QDs in collagen-HA composite gels. *Experimental data
show a significantly higher percentage of QD-DHLA-PEG in the fast component compared to QD-
DHLA (p < 0.05). Error bars represent 1 S.E.M.
In the case of collagen gels (Figure 29), a significantly higher percentage of QD-
DHLA-PEG traveled in the fast phase compared to QD-DHLA-PEG-NH2 (*).
There was no significant difference between QD-DHLA-PEG and QD-DHLA.
Comparison between gel types with same QD samples also show not significant
variation in their subpopulation fractions.
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30), it appears that QD-DHLA-PEG moves the fastest in both gels, but the
differences were not statistically significant, with the exception of the difference
between QD-DHLA-PEG and QD-DHLA in the collagen gels (4). The results of
the slow component diffusion coefficient showed a significant difference
between QD-DHLA and QD-DHLA-PEG-NH2 in collagen-HA ( B), as well as a
difference between QD-DHLA and QD-DHLA-PEG in collagen (*). More
interestingly, when comparing the two different gels, we observed that the
diffusion coefficient for both cationic (+ ) and anionic (***) QDs were faster in the
collagen-HA composite gel compared to the collagen gel.
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QD-DHLA-PEG-NH2
Figure 30. Fast component diffusion coefficients (D1) of QDs in gels. + Experimental data show
a significantly higher diffusion coefficient of QD-DHLA-PEG in the fast component compared to
QD-DHLA (p < 0.05) in collagen. Error bars represent 1 S.E.M.
*Collagen-HA
MCollagen
T*
QD-DHLA QD-DHLA-PEG QD-DHLA-PEG-NH2
Figure 31. Slow component diffusion coefficients (D2) of QDs in gels. * Experimental data show
a significantly higher diffusion coefficient of QD-DHLA-PEG than t compared to QD-DHLA in
collagen. k Diffusion coefficient of QD-DHLA-PEG-NH2 significantly higher than QD-DHLA in
collagen-HA. * Diffusion coefficient of QD-DHLA significantly higher in collagen-HA vs. collagen.
4- Diffusion coefficient of QD-DHLA-PEG-NH 2 significantly higher in collagen-HA vs. collagen.
For all cases listed, p < 0.05. Error bars represent 1 S.E.M.
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This two-component model could depict a fast fluid-like phase and a slower, gel-
like phase. Using this model, we would expect that the fast phase correspond to
water-filled areas in the pores of the gels and the slow phase be correlated to the
gel phase of collagen and HA. The effect of charge should be especially evident
in the slow phase because of the interaction between the QDs with collagen and
HA. Binding should result in a higher fraction of QDs traveling in the slow phase
while electrostatic repulsion should increase the fraction of QDs traveling in the
fast phase. Nonetheless, the results obtained through this fitting model did not
support such a description and the effect of charge on the transport of could not
be determined.
Despite the inconclusive results provided by this model, we can still gain some
insight. For all samples and both gels, the slow component was slower than the
fast component by approximately two orders of magnitude, which is agreement
with the findings of in vivo studies57. In both gels, around 60% of QD-DHLA-
PEG traveled in the fast phase, which matches in vivo subpopulation fraction
measurements of a similar-size antibody - nonspecific IgG (hydrodynamic
radius, 6.4 nm) in the tumor interstitium. The ratio of the fast component
diffusion coefficient and the diffusion coefficient in free solution, D1/Do of QD-
DHLA-PEG is between 0.35 - 0.36, which also falls in the range reported
previously. Of course, we must bear in mind that the in vivo measurements were
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carried out in Mu89, which has higher collagen content compared to our gels.
Thus, such comparisons are only useful in terms of the order of magnitude.
On the other hand, if we scale DI of QD-DHLA-PEG both gels from room
temperature to 34*C (by the Stokes-Einstein equation), we obtain values around
ranging from around 1.8 x 10-7 to 2.3 x 10-7 cm 2 /s, which agrees with in vivo
diffusion data for IgG in LS174T (1.29 x 10-7 - 2.77 x 10-7 cm 2 /s) reported by Netti
et al.34 This comparison is much more informative, given that both of our gels
have similar collagen and HA content as LS174T. It indicates that both the
collagen and collagen-HA gels are good models of the tumor interstitium
quantitatively. The fact that the fast component of our gel measurements
resemble the overall diffusion coefficient measured by Netti et al. using
fluorescence recovery after photobleaching (FRAP) also suggests that FRAP
might not be able to detect the slow component which is two orders of
magnitude smaller. The presence of such a slow moving component would
probably be factored into the bound fraction that leads to incomplete recovery of
the FRAP curve.
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4.5 Conclusions
By utilizing MPFCS, the transport of charged QDs in gel models of the tumor
interstitium was probed. Overall, the gels served as good models of the tumor
for quantitative experiments. A simple diffusion model could not describe the
diffusion of charged QDs in collagen and collagen-HA gels. Two other models -
anomalous subdiffusion and two-component free diffusion were used to analyze
the experimental data. Using the anomalous subdiffusion model, we conclude
that charge played a significant role in the diffusion of QDs as neutral QD-
DHLA-PEG diffused the fastest compared to the cationic QD-DHLA-PEG-NH 2
and anionic QD-DHLA. The results using a two-component diffusion model did
not provide a clear effect of charge on QD diffusion.
Although the results were statistically significant, the lack of a big difference
between different charged QDs could be due to their relatively small size, since
Johnson et al. reported that the ionic strength of agarose gels had no effect on the
diffusion of BSA 60. Perhaps a bigger difference in the zeta potential of each
sample is also needed and/or a higher concentration of HA in order for
electrostatic interactions to play a more significant role. Alternatively, our
measurements might not have provided a complete picture because FCS
measurements were limited to areas free from aggregation and high
concentration. Thus, there is a need to combine FCS with other techniques, such
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as FRAP to provide flexibility in measurements and construct a more detailed
picture of the effect of surface charge on nanoparticle transport in the tumor
interstitium.
81
References
1. Jemal, A. et al. Cancer statistics, 2007. CA Cancer J Clin 57, 43-66 (2007).
2. Ferrari, M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5,
161-71 (2005).
3. Kim, G.J. & Nie, S. Targeted cancer nanotherapy. Materials Today 8, 28-33 (2005).
4. Desai, N. Poster discussion session from the San Antonio Breast Cancer Society. San
Antonio Breast Cancer Society, San Antonio, Tx (2004).
5. Jain, R.K. The next frontier of molecular medicine: delivery of therapeutics. Nature
Medicine 4, 655-657 (1998).
6. Jain, R.K. Delivery of molecular and cellular medicine to solid tumors. Adv. Drug Deliv.
Rev. 46, 149-168 (2001).
7. Ehdaie, B. Application of Nanotechnology in Cancer Research: Review of Progress in the
National Cancer Institute's Alliance for Nanotechnology. /nt J Biol Sci 3, 108-10 (2007).
8. Whitesides, G.M. The 'right' size in nanobiotechnology. Nat Biotechnol 21, 1161-5 (2003).
9. La Van, D.A., McGuire, T. & Langer, R. Small-scale systems for in vivo drug delivery.
Nature Biotechnol. 21, 1184-1191 (2003).
10. McNeil, S.E. Nanotechnology for the biologist. J Leukoc Biol 78, 585-94 (2005).
11. Chen, L.T. & Weiss, L. The role of the sinus wall in the passage of erythrocytes through
the spleen. Blood 41, 529-37 (1973).
12. Bailey, F.R., Copenhaver, W.M., Bunge, R.P. & Bunge, M.B. Bailey's Textbook of
Histology, (Williams & Wilkins, Baltimore, MD, 1971).
13. Braet, F. et al. Structure and dynamics of the fenestrae-associated cytoskeleton of rat
liver sinusoidal endothelial cells. Hepatology 21, 180-9 (1995).
14. Morawski, A.M. et al. Targeted nanoparticles for quantitative imaging of sparse molecular
epitopes with MRI. Magn Reson Med 51, 480-6 (2004).
15. Storm, G., Belliot, S.O., Daemen, T. & Lasic, D.D. Surface modification of nanoparticles
to oppose uptake by the mononuclear phagocyte system. Advanced Drug Delivery
Reviews 17, 31-48 (1995).
16. Jain, R.K. Transport of molecules, particles, and cells in solid tumors. Annu Rev Biomed
Eng 1, 241-63 (1999).
17. Matsumura, Y. & Maeda, H. A new concept for macromolecular therapies in cancer
chemotherapy: mechanisms of tumortropic accumulation of proteins and the antitumor
agents SMANCS. Cancer Res. 6, 6397-6392 (1986).
18. Hobbs, S.K. et al. Regulation of transport pathways in tumor vessels: role of tumor type
and microenvironment. Proc Natl Acad Sci U S A 95, 4607-12 (1998).
19. Yuan, F. et al. Vascular permeability in a human tumor xenograft: molecular size
dependence and cutoff size. Cancer Research 55, 3752-3756 (1995).
20. Duncan, R. The dawning era of polymer therapeutics. Nature Rev. Drug Discov. 2, 347-
360 (2003).
21. Gref, R. et al. Biodegradable long-circulating polymeric nanospheres. Science 263, 1600-
3(1994).
22. Moghimi, S.M. & Szebeni, J. Stealth liposomes and long circulating nanoparticles: critical
issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res
42, 463-78 (2003).
23. Campbell, R.B. et al. Cationic charge determines the distribution of liposomes between
the vascular and extravascular compartments of tumors. Cancer Research 62, 6831-
6836 (2002).
24. Krasnici, S. et al. Effect of the surface charge of liposomes on their uptake by angiogenic
tumor vessels. /nt J Cancer 105, 561-567 (2003).
25. Thurston, G. et al. Cationic liposomes target angiogenic endothelial cells in tumors and
chronic inflammation in mice. J Clin /nvest 101, 1401-1413 (1998).
26. Murray, C.B., Norris, D.J. & Bawendi, M.G. Synthesis and characterization of nearly
monodisperse CdE (E=S, Se, Te) semiconductor nanocrystallites
J. Am. Chem. Soc. 115, 8706-8715 (1993).
82
27. Larson, D.R. et al. Water-soluble quantum dots for multiphoton fluorescence imaging in
vivo. Science 300, 1434-1436 (2003).
28. Stroh, M. et al. Quantum dots spectrally distinguish multiple species within the tumor
milieu in vivo. Nat Med 11, 678-682 (2005).
29. Tada, H., Higuchi, H., Wanatabe, T.M. & Ohuchi, N. In vivo real-time tracking of single
quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice. Cancer
Res 67, 1138-44 (2007).
30. Kim, S. et al. Near-infrared fluorescent type 11 quantum dots for sentinel lymph node
mapping. Nat Biotechnol 22, 93-7 (2004).
31. Soltesz, E.G. et al. Sentinel lymph node mapping of the gastrointestinal tract by using
invisible light. Ann Surg Oncol 13, 386-96 (2006).
32. Gao, X., Cui, Y., Levenson, R.M., Chung, L.W. & Nie, S. In vivo cancer targeting and
imaging with semiconductor quantum dots. Nat Biotechnol 22, 969-76 (2004).
33. Aukland, K. & Reed, R. Interstitial-lymphatic mechanisms in the control of extracellular
fluid volume. Physiol Rev 73, 1-78 (1993).
34. Netti, P., Berk, D., Swartz, M., Grodzinsky, A. & Jain, R. Role of extracellular matrix
assembly in interstitial transport in solid tumors. Cancer Res 60, 2497-503 (2000).
35. Jain, R.K. Transport of molecules in the tumor interstitium: a review. Cancer Research
47, 3039-3051 (1987).
36. Gersh, I. & Catchpole, H.R. The nature of ground substance of connective tissue.
Perspect Biol Med 3, 282-319 (1960).
37. Laurent, T.C. Structure, function, and turnover of the extracellular matrix. Adv. Microcirc.
13, 15-34 (1987).
38. Gullino, P.M. & Grantham, F.H. The influence of the host and the neoplastic cell
population on the collagen content of a tumor mass. Cancer Res 23, 648-653 (1963).
39. Scott, J.E. Collagen--proteoglycan interactions. Localization of proteoglycans in tendon
by electron microscopy. Biochem J 187, 887-91 (1980).
40. Pluen, A. et al. Role of tumor-host interactions in interstitial diffusion of macromolecules:
cranial vs. subcutaneous tumors. Proc Nat Acad Sci USA 98, 4628-33 (2001).
41. Oxlund, H., Manschot, J. & Viidik, A. The role of elastin in the mechanical properties of
skin. J Biomech 21, 213-8 (1988).
42. Prehm, P. Hyaluronate is synthesized at plasma membranes. Biochem J 220, 597-600
(1984).
43. Roden, L. Structure and metabolism of connective tissue proteoglycans. in The
Biochemistry of Glycoproteins and Proteoglycans (ed. Lennarz, W.L.) 267-371 (Plenum,
New York, 1980).
44. Leach, J.B. & Schimdt, C.E. Hyaluronan. in Encyclopedia of Biomaterials amd Biomedical
Engineering 779-789 (Markus Dekker, Inc., New York, 2004).
45. Laurent, T.C. & Fraser, J.R. Hyaluronan. Faseb J 6, 2397-404 (1992).
46. Comper, W.D. & Laurent, T.C. Physiological function of connective tissue
polysaccharides. Physiol Rev 58, 255-315 (1978).
47. Li, S. & Katz, E. An electrostatic model for collagen fibrils. The interaction of reconstituted
collagen with Ca++, Na+, and Cl-. Biopolymers 15,1439-60 (1976).
48. Wiig, H., Gyenge, C.C. & Tenstad, 0. The interstitial distribution of macromolecules in rat
tumours is influenced by the negatively charged matrix components. J Physiol 567, 557-
67 (2005).
49. Bert, J.L. & Pearce, R.H. The interstitium and microvascular exchange. in Handbook of
Physiology, Vol. IV (eds. Renkin, E.M. & Michel, C.C.) 521-547 (American Physiology
Society, Bethasda, MD, 1984).
50. Katz, E.P. & Li, S.T. The intermolecular space of reconstituted collagen fibrils. J Mol Biol
73, 351-69 (1973).
51. Granger, H.J., Dhar, J. & Chen, H.I. Dynamics and control of transmicrovascular fluid
exchange. in Edema (ed. Staub, N.C.) 189-228 (Raven, New York, 1984).
52. Boucher, Y., Baxter, L.T. & Jain, R.K. Interstitial pressure gradients in tissue-isolated and
subcutaneous tumors: implications for therapy. Cancer Res 50, 4478-84 (1990).
83
53. Netti, P.A. et al. Enhancement of fluid filtration across tumor vessels: implication for
delivery of macromolecules. Proc Natl Acad Sci U S A 96, 3137-42 (1999).
54. Nugent, L. & Jain, R. Extravascular diffusion in normal and neoplastic tissues. Cancer
Res 44, 238-44 (1984).
55. Gullino, P.M., Grantham, F.H. & Smith, S.H. The Interstitial Water Space of Tumors.
Cancer Res 25, 727-31 (1965).
56. Nugent, L. & Jain, R. Plasma pharmacokinetics and interstitial diffusion of
macromolecules in a capillary bed. Am J Physiol 246, H 129-37 (1984).
57. Alexandrakis, G. et al. Two-photon fluorescence correlation microscopy reveals the two-
phase nature of transport in tumors. Nature Medicine 10, 203-207 (2004).
58. Pluen, A., Netti, P.A., Jain, R.K. & Berk, D.A. Diffusion of macromolecules in agarose
gels: comparison of linear and globular configurations. Biophys J 77, 542-52 (1999).
59. Deen, W.M., Bohrer, M.P. & Epstein, N.B. Effects of molecular size and configuration on
diffusion in microporous membranes. Am. Inst. Chem. Eng. J. 27, 952-959 (1981).
60. Johnson, E., Berk, D., Jain, R. & Deen, W. Diffusion and partitioning of proteins in
charged agarose gels. Biophys J 68, 1561-8 (1995).
61. Ramanujan, S. et al. Diffusion and convection in collagen gels: implications for transport
in the tumor interstitium. Biophys J 83, 1650-60 (2002).
62. Magde, M., Elson, E. & Webb, W. Fluorescence correlation spectroscopy. II. An
experimental realization. Biopolymers 13, 29-61 (1974).
63. Elson, E. Fluorescence correlation spectroscopy. 1. Conceptual basis and theory.
Biopolymers 13, 1-27 (1974).
64. Magde, D., Webb, W.W. & Elson, E.L. Fluorescence correlation spectroscopy. Ill.
Uniform translation and laminar flow. Biopolymers 17, 361 - 376 (1978).
65. Icenogle, R.D. & Elson, E.L. Fluorescence correlation spectroscopy and photobleaching
recovery of multiple binding reactions. II. FPR and FCS measurements at low and high
DNA concentrations. Biopolymers 22, 1949-66 (1983).
66. Icenogle, R.D. & Elson, E.L. Fluorescence correlation spectroscopy and photobleaching
recovery of multiple binding reactions. 1. Theory and FCS measurements. Biopolymers
22, 1919-48 (1983).
67. Elson, E.L. & Webb, W.W. Concentration correlation spectroscopy: a new biophysical
probe based on occupation number fluctuations. Annu Rev Biophys Bioeng 4, 311-34
(1975).
68. Elson, E. Quick tour of fluorescence correlation spectroscopy from its inception. J Biomed
Opt 9, 857-64 (2004).
69. Berland, K.M., So, P.T. & Gratton, E. Two-photon fluorescence correlation spectroscopy:
method and application to the intracellular environment. Biophys J 68, 694-701 (1995).
70. Qian, H. & Elson, E.L. Analysis of confocal laser-microscope optics for 3-D fluorescence
correlation spectroscopy. Appl. Optics 30, 1185-1195 (1991).
71. Rigler, R., Mets, U., Widengren, J. & Kask, P. Fluorescence correlation spectroscopy with
high count rate and low background: analysis of translational diffusion. Eur. Biophys. J,
22, 169-175 (1993).
72. Schwille, P., Haupts, U., Maiti, S. & Webb, W.W. Molecular dynamics in living cells
observed by fluorescence correlation spectroscopy with one- and two-photon excitation.
Biophys J 77, 2251-65 (1999).
73. Liedl, T., Keller, S., Simmel, F., Radler, J. & Parak, W. Fluorescent nanocrystals as
colloidal probes in complex fluids measured by fluorescence correlation spectroscopy.
Small (Weinheim an der Bergstrasse, Germany) 1, 997-1003 (2005).
74. Schwille, P. & Haustein, E. Fluorescence correlation spectroscopy: An introduction to its
concepts and applications. (Biophys. J.).
75. Zipfel, W.R., Williams, R.M. & Webb, W.W. Nonlinear magic: multiphoton microscopy in
the biosciences. Nat Biotechnol 21, 1369-77 (2003).
76. Periasamy, A., Zipfel, W.R. & Webb, W.W. (eds.). Methods in cellular imaging, 434
(Oxford University Press, Oxford, 2001).
77. Richards, B. & Wolf, E. Electromagnetic diffraction in the optical systems 1I. Structure of
the image field in a planatic system. Proc. R. Soc. Lond. Ser. A 253, 358-379 (1959).
84
78. Denk, W., Strickler, J.H. & Webb, W.W. Two-photon laser scanning fluorescence
microscopy. Science 248, 73-6 (1990).
79. lyer, V., Rossow, M., Waxham, M. & Periasamy, A. Focal volume characterization using
multiphoton fluorescence correlation spectroscopy (MP-FCS). Proceedings of SPIE
(2004).
80. Neil, M.A.A., Juskaitis, R. & Wilson, T. Method of obtaining optical sectioning by using
structured light in a conventional microscope Optics Letters 22, 1905-1907 (1997).
81. Jain, R.K., Stock, R.J., Chary, S.R. & Rueter, M. Convection and diffusion measurements
using fluorescence recovery after photobleaching and video image analysis: in vitro
calibration and assessment. Microvasc Res 39, 77-93 (1990).
82. Doose, S., Tsay, J., Pinaud, F. & Weiss, S. Comparison of photophysical and colloidal
properties of biocompatible semiconductor nanocrystals using fluorescence correlation
spectroscopy. Anal Chem 77, 2235-42 (2005).
83. Nirmal, M. et al. Fluorescence intermittency in single cadmium selenide nanocrystals.
Nature 383, 802-804 (1996).
84. Periasamy, N. & Verkman, A.S. Analysis of fluorophore diffusion by continuous
distributions of diffusion coefficients: application to photobleaching measurements of
multicomponent and anomalous diffusion. Biophys J. 75, 557-567 (1998).
85
